WIM
PLSE icon

Westside Investment Management’s Pulse Biosciences PLSE Stock Holding History

Westside Investment Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Buy
70,492
+4,166
+6% +$76.9K 0.23% 104
2025
Q4 		$911K Buy
66,326
+1,886
+3% +$29.4K 0.15% 128
2025
Q3 		$1.14M Buy
64,440
+150
+0.2% +$2.37K 0.18% 114
2025
Q2 		$970K Buy
64,290
+6,135
+11% +$102K 0.18% 116
2025
Q1 		$936K Buy
58,155
+3,034
+6% +$56.6K 0.2% 113
2024
Q4 		$960K Buy
55,121
+125
+0.2% +$2.2K 0.2% 115
2024
Q3 		$965K Sell
54,996
-8,604
-14% -$147K 0.21% 118
2024
Q2 		$712K Buy
63,600
+31,440
+98% +$296K 0.16% 126
2024
Q1 		$280K Sell
32,160
-2,015
-6% -$18.5K 0.07% 194
2023
Q4 		$418K Sell
34,175
-24,583
-42% -$170K 0.11% 154
2023
Q3 		$237K Sell
58,758
-11,377
-16% -$70.7K 0.07% 189
2023
Q2 		$504K Sell
70,135
-40,966
-37% -$262K 0.14% 134
2023
Q1 		$373K Sell
111,101
-27,508
-20% -$83K 0.11% 156
2022
Q4 		$383 Sell
138,609
-6,114
-4% -$13.7K ﹤0.01% 291
2022
Q3 		$332 Sell
144,723
-33,472
-19% -$54.4K ﹤0.01% 306
2022
Q2 		$272 Buy
178,195
+52,166
+41% +$131K ﹤0.01% 309
2022
Q1 		$612 Buy
126,029
+91,367
+264% +$748K ﹤0.01% 285
2021
Q4 		$513 Buy
34,662
+525
+2% +$10.5K ﹤0.01% 280
2021
Q3 		$737 Buy
34,137
+228
+0.7% +$4.91K ﹤0.01% 264
2021
Q2 		$556 Buy
33,909
+1,541
+5% +$29.3K ﹤0.01% 264
2021
Q1 		$766 Buy
32,368
+906
+3% +$27.1K ﹤0.01% 246
2020
Q4 		$750 Sell
31,462
-2,146
-6% -$34.1K ﹤0.01% 207
2020
Q3 		$396 Sell
33,608
-2,113
-6% -$22.7K ﹤0.01% 232
2020
Q2 		$373 Buy
35,721
+8,661
+32% +$78K ﹤0.01% 212
2020
Q1 		$193 Buy
+27,060
New +$281K ﹤0.01% 238
2019
Q2 		$5.07K Buy
+20,650
New +$282K 0.01% 79
2018
Q4 		$201K Sell
17,525
-2,500
-12% -$30.2K 0.07% 156
2018
Q3 		$245K Buy
20,025
+2,600
+15% +$36.9K 0.08% 132
2018
Q2 		$278K Buy
17,425
+2,150
+14% +$36.4K 0.1% 131
2018
Q1 		$214K Buy
+15,275
New +$290K 0.12% 150

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Westside Investment Management's PLSE Position: Q1 2026 in Review

Westside Investment Management increased its Pulse Biosciences (PLSE) stake by 6.3% in Q1 2026, buying an estimated $76.9K and bringing the position to 70,492 shares worth $1.52M. The position accounts for 0.23% of the portfolio, ranked #104.

Westside Investment Management first reported a position in PLSE in Q1 2018 and has held it in 30 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Westside Investment Management held 70,492 shares of Pulse Biosciences worth $1.52M as of Q1 2026.
  • Westside Investment Management bought 4,166 Pulse Biosciences shares in Q1 2026, an estimated $76.9K.
  • Pulse Biosciences made up 0.23% of Westside Investment Management's portfolio in Q1 2026, its #104 holding.
  • Westside Investment Management first reported a position in Pulse Biosciences in Q1 2018 and has held it in 30 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Westside Investment Management's 13F filing for Q1 2026, filed 4 May 2026.